Which pill stops the itch? new study pits methotrexate against apremilast for psoriasis sufferers
NCT ID NCT07432386
First seen Mar 06, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study will test two oral medications, methotrexate and apremilast, to see which one better reduces itching and improves quality of life in people with psoriasis. Eighty adults with psoriasis covering more than 8% of their body and related itching will take one of the drugs for 8 weeks. The main goal is to measure changes in skin-related quality of life and itch severity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pak Emirates Military Hospital
Rawalpindi, Punjab Province, 46000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.